Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > not sure about the wording

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Nov 27, 2024 9:17pm

313 Views

Post# 36334870

not sure about the wording

It will be interesting to hear clarification on the investor call Dec 4 as I'm not sure about the wording around the pre-btd. It is so similar to previous that I don't know if I am convinced that it is saying, we resubmitted for pre-BTD and now, for the 2nd time, they want clarification. That would make the 3rd crack at pre-BTD which is absurd as usually if you are not BTD worthy you get that feedback on the first or second go. Having the FDA say, no but try again in a month makes no sense.

So I'm confused.

<< Previous

Bullboard Posts

Next >>

Near-term and long-term outlook for gold